Zhejiang Xinguang Pharmaceutical Management
Management criteria checks 4/4
Zhejiang Xinguang Pharmaceutical's CEO is Yue Jun Wang, appointed in Aug 2012, has a tenure of 12.33 years. directly owns 38.25% of the company’s shares, worth CN¥844.56M. The average tenure of the management team and the board of directors is 12.3 years and 6.3 years respectively.
Key information
Yue Jun Wang
Chief executive officer
CN¥204.6k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 12.3yrs |
| CEO ownership | 38.3% |
| Management average tenure | 12.3yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
Earnings Not Telling The Story For Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519) After Shares Rise 38%
Oct 18
Zhejiang Xinguang Pharmaceutical (SZSE:300519) Has Announced That Its Dividend Will Be Reduced To CN¥0.40
May 26Calculating The Intrinsic Value Of Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519)
Apr 16Zhejiang Xinguang Pharmaceutical Co., Ltd.'s (SZSE:300519) Low P/E No Reason For Excitement
Feb 26CEO
Yue Jun Wang (70 yo)
12.3yrs
Tenure
CN¥204,600
Compensation
Mr. Yue Jun Wang has been Chairman of the Board and General Manager at Zhejiang Xinguang Pharmaceutical Co., Ltd. since August 25, 2012 and serves as its Director. Mr. Wang was Deputy director of pharmacis...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 12.3yrs | CN¥204.60k | 38.25% CN¥ 844.6m | |
| CFO & Director | 10yrs | CN¥163.40k | no data | |
| Deputy GM & Director | 12.3yrs | CN¥162.00k | no data | |
| Deputy GM | 12.3yrs | CN¥165.10k | no data |
12.3yrs
Average Tenure
59yo
Average Age
Experienced Management: 300519's management team is seasoned and experienced (12.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 12.3yrs | CN¥204.60k | 38.25% CN¥ 844.6m | |
| CFO & Director | 6.3yrs | CN¥163.40k | no data | |
| Deputy GM & Director | 12.3yrs | CN¥162.00k | no data | |
| Deputy GM | 12.3yrs | CN¥165.10k | no data | |
| Non-Employee Supervisor | less than a year | CN¥117.00k | no data | |
| Chairman of the Supervisory Board | 6.3yrs | no data | no data | |
| Supervisor | 6.3yrs | no data | no data | |
| Non Independent Director | 6.3yrs | CN¥83.60k | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Non-Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
6.3yrs
Average Tenure
56yo
Average Age
Experienced Board: 300519's board of directors are considered experienced (6.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 12:18 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhejiang Xinguang Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|